Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Latest News
    • Mankind Pharma...

    Mankind Pharma launches constipation drug with Rishi Kapoor as brand ambassador

    Written by Ruby Khatun Khatun Published On 2018-08-04T16:45:59+05:30  |  Updated On 4 Aug 2018 4:45 PM IST
    Mankind Pharma launches constipation drug with Rishi Kapoor as brand ambassador

    Kolkata: Mankind Pharma, a quality-driven pharmaceutical company in India has launched a new Over-the-counter (OTC) product – ‘KABZEND Natural Laxative Granules’ to help relieve constipation.


    Mankind Pharma has chosen Veteran Actor Rishi Kapoor as the brand ambassador of its new product. KABZEND is an Ayurvedic-based formulation that will help maintain regular bowel movements and ensure proper cleansing of the body.


    The product is available in the market at an affordable price of Rs. 50 per 50gm. Change in lifestyle and lack of proper nutrition is leading to rising problems of constipation, which in long-term results in serious health issues.


    KABZEND is a blend of time-tested potent & quality herbs to effectively pacify the problems leading to gastrointestinal disorders such as constipation, indigestion, gas and irregular bowel syndrome. Herbs used in the formulation of KABZEND are undertaken with intense care and good manufacturing guidelines to ensure quality standards, making it safe for consumption.


    Mr Rajeev Juneja, CEO, Mankind Group said, “At Mankind, we endeavor to bring the latest innovative therapies with assured quality that address primary healthcare challenges in India. We promise to deliver world-class quality at affordable prices. It is with this thought we decided to launch KABZEND at the affordable price of Rs 50 per 50 gm.”


    He further added, “Having a personality like Mr. Amitabh Bachchan as brand ambassador for Mankind Pharma has helped us increase connect amongst the consumers. With this vision, we have chosen Mr. Rishi Kapoor for our newest product - KABZEND. We believe having such personalities will help us in strengthening our image amongst our consumers.”


    Inspired by Pradhan Mantri Jan Aushadi Scheme to deliver pharmaceuticals products at affordable prices, Mankind Pharma with its Make in India approach has set up goals to sustain a balance in the healthcare of the country.

    Amitabh Bachchanayurvedicbrand ambassadorconstipationgastrointestinal disordersindigestionirregular bowel syndromeKABZENDKABZEND Natural Laxative GranuleslaunchesMankind PharmaOTCover-the-counterPradhan Mantri Jan Aushadi SchemeRajeev JunejaRishi Kapoor
    Source : UNI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    Ruby Khatun Khatun
    Ruby Khatun Khatun
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok